相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer Preparing for the Future
Philippe Fournier et al.
BIODRUGS (2013)
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
Jie Ni et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development
Corinne Vannier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions
Chuan-Jin Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
EpCAM regulates cell cycle progression via control of cyclin D1 expression
A. Chaves-Perez et al.
ONCOGENE (2013)
Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y
Petra Massoner et al.
PLOS ONE (2013)
Regulated Intramembrane Proteolysis and Degradation of Murine Epithelial Cell Adhesion Molecule mEpCAM
Matthias Hachmeister et al.
PLOS ONE (2013)
Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer
Goran Benko et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
Agnieszka Martowicz et al.
BMC CANCER (2012)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy
Diane Seimetz et al.
CANCER TREATMENT REVIEWS (2010)
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun et al.
CARCINOGENESIS (2010)
Initial activation of EpCAM cleavage via cell-to-cell contact
Sabine Denzel et al.
BMC CANCER (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
Tyrol Prostate Cancer Demonstration Project: Early detection, treatment, outcome, incidence and mortality
Georg Bartsch et al.
BJU INTERNATIONAL (2008)
A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators
K. Maaser et al.
BRITISH JOURNAL OF CANCER (2008)
Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
Markus Munz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Review: Biological relevance of disseminated tumor cells in cancer patients
Sabine Riethdorf et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia
C. Ploner et al.
LEUKEMIA (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule
Monika Trzpis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
M. A. Chaudry et al.
BRITISH JOURNAL OF CANCER (2007)
hTERT-immortalized prostate epithelial and stromal-derived cells:: an authentic in vitro model for differentiation and carcinogenesis
I Kogan et al.
CANCER RESEARCH (2006)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
P Went et al.
BRITISH JOURNAL OF CANCER (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
M Münz et al.
ONCOGENE (2004)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
In vitro and in vivo pharmacology and pharmacokinetics of a Human Engineered™ monoclonal antibody to epithelial cell adhesion molecule
WS Ammons et al.
NEOPLASIA (2003)
Presenilin dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch
M Sastre et al.
EMBO REPORTS (2001)
Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (αEpCAM x αCD3)
R Riesenberg et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors
DAM Heideman et al.
CANCER GENE THERAPY (2001)
Ep-CAM overexpression in breast cancer as a predictor of survival
G Gastl et al.
LANCET (2000)
The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung
CJ Piyathilake et al.
HUMAN PATHOLOGY (2000)
分享论文
